Earnings
Halozyme CEO Says Dutch Ruling Hits Merck's Italian Keytruda Plant And Halozyme Has Sued It
CEO Helen Torley says Halozyme has not spoken to Merck, and the Dutch order covers eight markets that, with Germany, are about 20% of royalties.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Earnings
CEO Helen Torley says Halozyme has not spoken to Merck, and the Dutch order covers eight markets that, with Germany, are about 20% of royalties.
SEC Filings
Visa paid $3.64 billion from its legal escrow in fiscal 2026, against $974 million a year earlier, and deposited $1.28 billion.
Earnings
Heavy Permian plant spending left little free cash in the third quarter while Targa's total debt reached $19,844.5 million.
Insider Trades
Shah still holds 8,762,490 Wayfair shares across both classes after the Tuesday conversion.
Earnings
Guardant raised its full-year screening outlook after Shield sales hit $68 million, though a billing-code gap will delay some cash.
Earnings
Fulgent raised its cash forecast to about $630 million and cut its expected loss per share, while its billing overhaul remains unfinished.
SEC Filings
SDG&E's Wildfire Fund asset slipped from $248 million in June as rivals drew on it, and a San Clemente fire now has a lawsuit aimed at its own utility.
Earnings
Eton's CEO pitched nine pipeline programs and bigger deals after revenue of $57.9 million, and explained why guidance stays conservative.
Insider Trades
The proposed sale by the Roper Technologies chief is valued at $19.7 million, with Charles Schwab named as broker.
SEC Filings
Buybacks shrank to $75 million as the motion-control maker borrowed to fund its largest deal.
Earnings
CEO Richard Miller says the wait keeps everyone blinded, and cash of $202.9 million should last into the second quarter of 2028.
Earnings
The third-quarter filing swaps the AI and billing-efficiency story for collections estimates catching up with cash, alongside a CEO change.